AI-based Adherence Prediction for Patients: Leveraging a Mobile Application to Improve Clinical Trials

In this video Rich Christie MD PhD discusses:

Non-adherence is a major public health concern and can impact the quality of data in clinical trials
Traditional compliance collection (pill counts, diaries) can be misleading and unreliable, especially in CNS trial
Pharmacokinetic sampling, adherence markers, and adherence technologies may play a critical role in trial outcomes
AiCure is a computer vision-assisted dosing mobile app that collects patient dosing data and connects patients to sites for ongoing dosing support
Boehringer Ingelheim is partnering with AiCure on several pilot trials to leverage AiCure adherence information to improve patient retention and data quality in clinical trials.